FairJourney Biologics acquires Charles River facility
03/04/25, 9:26 AM
Location
porto
wilmingtonIndustry
biotechnology
biotechnology
FairJourney Biologics S.A. has completed the acquisition of the South San Francisco site from Charles River Laboratories. This strategic acquisition enhances FairJourney’s capabilities in antibody discovery and engineering. The integration of Charles River's proprietary technologies will strengthen FairJourney’s portfolio, enabling them to offer more diverse solutions. The deal positions FairJourney to expand its presence in a key biotechnology hub.
Company Info
Location
Porto, Porto, Portugal
Company info
At FairJourney Biologics, we specialize in cutting-edge antibody discovery and development, offering end-to-end solutions that fast-track your research. With over a decade of expertise, our innovative technologies and seasoned team have successfully advanced 14 antibodies to clinical stages.
Our adaptable partnership model empowers projects of any scale, fostering collaboration and breakthrough innovation. Whether you're in early-stage research or development, we deliver tailored, high-quality antibodies designed to meet your specific needs.